Regeneron (REGN) Tops Q2 EPS by $1.17
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $793.26 -1.78%
Revenue Growth %: +21.1%
Financial Fact:
Total other income (expense): 3.08M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +21.1%
Financial Fact:
Total other income (expense): 3.08M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q2 EPS of $9.77, $1.17 better than the analyst estimate of $8.60. Revenue for the quarter came in at $2.86 billion versus the consensus estimate of $2.79 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Copart to buy ACV for $1.9 billion in cash deal
- Regeneron Pharma (REGN) PT Raised to $920 at HSBC
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
